{"id":727085,"date":"2023-01-31T07:33:55","date_gmt":"2023-01-31T12:33:55","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/"},"modified":"2023-01-31T07:33:55","modified_gmt":"2023-01-31T12:33:55","slug":"microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/","title":{"rendered":"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"center\">\n        <em>Dr. Giora Weisz, a Practicing Interventional Cardiologist and Clinical Researcher who was One of the Early Users of Robotic-Enhanced Coronary Interventions, as well as Navigation and Positioning Technologies, Will be the Guest Speaker.<\/em><br \/>\n        \n      <\/p>\n<p align=\"center\">\n        <em>The Webinar is Intended for All Stakeholders Interested in the Future of Endovascular Robotics, and Will be Held on Wednesday, February 8, 2023, at 1:00pm ET<\/em>\u00a0\u00a0<\/p>\n<p align=\"justify\">HINGHAM, Mass., Jan.  31, 2023  (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY\u00ae Robotic System, the first single-use endovascular robotic system, announced the next episode of its highly successful \u201cAccess-Ability Live by MBOT\u201d webinar, which is intended for all stakeholders interested in the endovascular robotic space and will be held on Wednesday, February 8, 2023, at 1:00pm ET. It will be hosted by the Company\u2019s Chief Medical Officer, Dr. Eyal Morag.<\/p>\n<p align=\"justify\">Dr. Morag\u2019s guest speaker will be Dr. Giora Weisz, an interventional cardiologist and Associate Professor of Medicine at Columbia University Medical Center, Director of Interventional Cardiology at the New York-Presbyterian Hudson Valley Hospital, and a member of the faculty of the Center of Interventional Vascular Therapy at Columbia University Medical Center. He is also a faculty member at the Cardiovascular Research Foundation in New York. Dr. Weisz, who has a particular interest in current and innovative technologies in cardiovascular medicine, is an early adopter of robotic-enhanced coronary interventions, as well as navigation and positioning technologies. Dr. Weisz, who performed Corindus Vascular Robotics\u2019 (acquired by Siemens Healthineers) First-in-Human (FIH) clinical trial to evaluate the safety and technical efficacy of Corindus\u2019 CorePath system in delivering and manipulating coronary guidewires and stent\/balloon systems in PCI procedures and was the first to use this system on patients in the U.S., will share his personal experiences using a number of different endovascular robotic systems while addressing the current and future landscapes for endovascular procedures and the critical role of surgical robotics to address future medical needs.<\/p>\n<p align=\"justify\">The <strong>\u201c<em>Access-Ability Live by MBOT<\/em>\u201d<\/strong> webinar series focuses on key topics in the healthcare and endovascular space. Each month, the Company will be partnering with industry leaders, such as physicians, hospital administrators, entrepreneurs, technicians and financial experts for a live discussion and Q&amp;A session to address top-of-mind topics related to endovascular procedures.<\/p>\n<p align=\"justify\">You can register for the upcoming webinar here: <br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=_whC_afx6URRZ9i3CMBsXEzDwbCcI7NO88FNu0-DZnFASqUketZDMQ8KSEAGJVeNXfAQiOz1kYdIDABo2IgjPfrPsrmgkeoAX3JCt84YZBV_mzdngWqpYK8NzEITGvL93AyErP2sVLCjMq4omky9V1GoIc8Hp7yCl0b7Jff37EHtv5eVLqkecK2N-IbpoO6loIEEaXO8-mAWStk0X4y3xA==\" rel=\"nofollow noopener\" target=\"_blank\">https:\/\/us06web.zoom.us\/webinar\/register\/WN_iYewlRGNQDaXwE9H2cG28Q<\/a><\/p>\n<p>\n        <strong>About Microbot Medical<\/strong>\n      <\/p>\n<p align=\"justify\">Microbot Medical Inc. (NASDAQ: MBOT) is a pre-clinical medical device company that specializes in transformational micro-robotic technologies, focused primarily on both natural and artificial lumens within the human body. Microbot\u2019s current proprietary technological platforms provide the foundation for the development of a Multi Generation Pipeline Portfolio (MGPP).<\/p>\n<p align=\"justify\">Microbot Medical was founded in 2010 by Harel Gadot, Prof. Moshe Shoham, and Yossi Bornstein with the goals of improving clinical outcomes for patients and increasing accessibility through the use of micro-robotic technologies. Further information about Microbot Medical is available at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=r-o5XgiMguIc2tPMFEMAnVBpRfdC_ooZCM0Eg2R9SajPwIHp_2wZESgGvQXigXEH60Tf6jRZ3mPZy99u-0FWU-mrZpFs_94Gn8l4Cbn9lwphhZXCgHJIhmDXxvfbmjRr\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/www.microbotmedical.com<\/a>.<\/p>\n<p>\n        <strong>Safe Harbor<\/strong>\n      <\/p>\n<p align=\"justify\">Statements made in this press release or by members of Microbot\u2019s management team and others on Access-Ability Live, relating to future financial and\/or operating results, future growth in research, technology, clinical development, and potential opportunities for Microbot Medical Inc. and its subsidiaries, along with other statements about the future expectations, beliefs, goals, plans, or prospects expressed by management, constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and the Federal securities laws. Any statements that are not historical fact (including, but not limited to statements that contain words such as \u201cwill,\u201d \u201cbelieves,\u201d \u201cplans,\u201d \u201canticipates,\u201d \u201cexpects\u201d and \u201cestimates\u201d) should also be considered to be forward-looking statements. Forward-looking statements involve risks and uncertainties, including, without limitation, market conditions, risks inherent in the development and\/or commercialization of potential products, including LIBERTY and the One &amp; Done\u2122 technologies, the outcome of its studies to evaluate LIBERTY, the One &amp; Done\u2122 technologies and other existing and future technologies, any failure or inability to recruit physicians and clinicians to serve as primary investigators to conduct regulatory studies, which could adversely affect or delay such studies, uncertainty in the results of pre-clinical and clinical trials or regulatory pathways and regulatory approvals, uncertainty resulting from the COVID-19 pandemic, need and ability to obtain future capital, and maintenance of intellectual property rights. Additional information on risks facing Microbot Medical can be found under the heading \u201cRisk Factors\u201d in Microbot Medical\u2019s periodic reports filed with the Securities and Exchange Commission (SEC), which are available on the SEC\u2019s web site at www.sec.gov. Microbot Medical disclaims any intent or obligation to update these forward-looking statements, except as required by law.<\/p>\n<p align=\"justify\">Statements, views and opinions expressed by guests of the Access-Ability Live by MBOT webcast series are theirs solely, and do not necessarily reflect the statements, views and opinions of their employers, organizations and\/or associations, or of Microbot Medical Inc. and its subsidiaries. Certain guests of Access-Ability are members of the Scientific Advisory Board (SAB) of Microbot or paid consultants of Microbot, and have received compensation for their services to Microbot.<\/p>\n<p>\n        <strong>Investor Contact: <\/strong><br \/>\n        <br \/>Michael Polyviou<br \/>EVC Group<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LmNvvlDD2XXpH6bU20hluEbuVYj7e4GsmDeTXBfDJV3YZuvpTT-7drwRGIYuey4EPxK0p2HiahTRZScXmr5qfWidHkSZiXS2xrf8qkjHGdQ=\" rel=\"nofollow noopener\" target=\"_blank\">mpolyviou@evcgroup.com<\/a> | 732-933-2754<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/OWJjYzVkMDUtODM5YS00OWFlLWE3NzUtYmZlMGNlOTUyN2M2LTEwOTQwNjg=\/tiny\/Microbot-Medical-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Dr. Giora Weisz, a Practicing Interventional Cardiologist and Clinical Researcher who was One of the Early Users of Robotic-Enhanced Coronary Interventions, as well as Navigation and Positioning Technologies, Will be the Guest Speaker. The Webinar is Intended for All Stakeholders Interested in the Future of Endovascular Robotics, and Will be Held on Wednesday, February 8, 2023, at 1:00pm ET\u00a0\u00a0 HINGHAM, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY\u00ae Robotic System, the first single-use endovascular robotic system, announced the next episode of its highly successful \u201cAccess-Ability Live by MBOT\u201d webinar, which is intended for all stakeholders interested in the endovascular robotic space and will be held on Wednesday, February 8, 2023, at &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-727085","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"Dr. Giora Weisz, a Practicing Interventional Cardiologist and Clinical Researcher who was One of the Early Users of Robotic-Enhanced Coronary Interventions, as well as Navigation and Positioning Technologies, Will be the Guest Speaker. The Webinar is Intended for All Stakeholders Interested in the Future of Endovascular Robotics, and Will be Held on Wednesday, February 8, 2023, at 1:00pm ET\u00a0\u00a0 HINGHAM, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY\u00ae Robotic System, the first single-use endovascular robotic system, announced the next episode of its highly successful \u201cAccess-Ability Live by MBOT\u201d webinar, which is intended for all stakeholders interested in the endovascular robotic space and will be held on Wednesday, February 8, 2023, at &hellip; Continue reading &quot;Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-31T12:33:55+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series\",\"datePublished\":\"2023-01-31T12:33:55+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/\"},\"wordCount\":867,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/\",\"name\":\"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=\",\"datePublished\":\"2023-01-31T12:33:55+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/","og_locale":"en_US","og_type":"article","og_title":"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series - Market Newsdesk","og_description":"Dr. Giora Weisz, a Practicing Interventional Cardiologist and Clinical Researcher who was One of the Early Users of Robotic-Enhanced Coronary Interventions, as well as Navigation and Positioning Technologies, Will be the Guest Speaker. The Webinar is Intended for All Stakeholders Interested in the Future of Endovascular Robotics, and Will be Held on Wednesday, February 8, 2023, at 1:00pm ET\u00a0\u00a0 HINGHAM, Mass., Jan. 31, 2023 (GLOBE NEWSWIRE) &#8212; Microbot Medical Inc. (Nasdaq: MBOT), the developer of the LIBERTY\u00ae Robotic System, the first single-use endovascular robotic system, announced the next episode of its highly successful \u201cAccess-Ability Live by MBOT\u201d webinar, which is intended for all stakeholders interested in the endovascular robotic space and will be held on Wednesday, February 8, 2023, at &hellip; Continue reading \"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/","og_site_name":"Market Newsdesk","article_published_time":"2023-01-31T12:33:55+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series","datePublished":"2023-01-31T12:33:55+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/"},"wordCount":867,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/","name":"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=","datePublished":"2023-01-31T12:33:55+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODczOTQ3NSM1MzgyNDMwIzIwODI0OTc="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/microbot-medical-welcomes-distinguished-interventional-cardiologist-and-early-adopter-of-endovascular-robotics-to-its-next-access-ability-live-by-mbot-webinar-series\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Microbot Medical Welcomes Distinguished Interventional Cardiologist and Early Adopter of Endovascular Robotics to its Next \u201cAccess-Ability Live by MBOT\u201d Webinar Series"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727085","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=727085"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/727085\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=727085"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=727085"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=727085"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}